Comlex®
Otitis externa and media
LaunchedCommercial
Key Facts
About NANO mRNA
Japanese platform company generating mRNA therapeutic intellectual property using proprietary nanoparticle delivery technology.
View full company profileOtitis externa and media
Japanese platform company generating mRNA therapeutic intellectual property using proprietary nanoparticle delivery technology.
View full company profile